We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Renasant Corp
RNST
$4.02B
| $1.05M | ﹤0.01% |
38,926
+600
| +2% | +$17.2K |
|
|
WAIR
1727
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $1.05M | ﹤0.01% |
60,409
-100
| -0.2% | -$1.86K |
|
|
NAVG
1728
DELISTED
Navigators Group Inc
NAVG
| $1.05M | ﹤0.01% |
34,118
+500
| +1% | +$15.9K |
|
1729
Coherent
COHR
$56.4B
| $1.05M | ﹤0.01% |
88,917
+300
| +0.3% | +$4.08K |
|
1730
National CineMedia
NCMI
$392M
| $1.04M | ﹤0.01% |
7,205
| – | – |
|
1731
AMERISAFE
AMSF
$564M
| $1.04M | ﹤0.01% |
26,689
| – | – |
|
1732
Azenta
AZTA
$1.38B
| $1.04M | ﹤0.01% |
99,079
+250
| +0.3% | +$2.68K |
|
1733
City Holding Co
CHCO
$2.05B
| $1.04M | ﹤0.01% |
24,714
| – | – |
|
1734
Columbia Sportswear
COLM
$3B
| $1.03M | ﹤0.01% |
28,918
+50
| +0.2% | +$1.94K |
|
1735
Diageo
DEO
$49.2B
| $1.03M | ﹤0.01% |
8,955
| – | – |
|
1736
Ligand Pharmaceuticals
LGND
$5.85B
| $1.03M | ﹤0.01% |
35,231
-2,164
| -6% | -$71.8K |
|
1737
TSMC
TSM
$2.11T
| $1.03M | ﹤0.01% |
50,997
| – | – |
|
|
FRGI
1738
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.03M | ﹤0.01% |
20,694
-90
| -0.4% | -$4.28K |
|
|
NTUS
1739
DELISTED
Natus Medical Inc
NTUS
| $1.03M | ﹤0.01% |
34,827
+530
| +2% | +$14.6K |
|
1740
Artisan Partners
APAM
$2.99B
| $1.03M | ﹤0.01% |
19,710
-43
| -0.2% | -$2.32K |
|
|
IRBT
1741
DELISTED
iRobot
IRBT
| $1.02M | ﹤0.01% |
33,644
+350
| +1% | +$12K |
|
1742
Materion
MTRN
$4.45B
| $1.02M | ﹤0.01% |
33,355
-100
| -0.3% | -$3.4K |
|
1743
Simmons First National
SFNC
$3.45B
| $1.02M | ﹤0.01% |
53,090
+200
| +0.4% | +$3.97K |
|
1744
Interactive Brokers
IBKR
$39.1B
| $1.01M | ﹤0.01% |
162,600
+876
| +0.5% | +$5.21K |
|
|
CHL
1745
DELISTED
China Mobile Limited
CHL
| $1.01M | ﹤0.01% |
17,230
-500
| -3% | -$28.8K |
|
1746
Acacia Research
ACTG
$447M
| $1.01M | ﹤0.01% |
65,263
-100
| -0.2% | -$1.68K |
|
1747
Scotiabank
BNS
$108B
| $1.01M | ﹤0.01% |
17,422
| – | – |
|
|
CLVS
1748
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.01M | ﹤0.01% |
22,261
-1,630
| -7% | -$68.1K |
|
1749
Acco Brands
ACCO
$399M
| $1.01M | ﹤0.01% |
146,206
+400
| +0.3% | +$2.8K |
|
1750
Exponent
EXPO
$3.31B
| $1.01M | ﹤0.01% |
56,780
+200
| +0.4% | +$3.67K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.